These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 35836227)
1. Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer. Huang Z; Yan Y; Wang T; Wang Z; Cai J; Cao X; Yang C; Zhang F; Wu G; Shen B J Transl Med; 2022 Jul; 20(1):315. PubMed ID: 35836227 [TBL] [Abstract][Full Text] [Related]
2. Multi-omics reveals the role of ENO1 in bladder cancer and constructs an epithelial-related prognostic model to predict prognosis and efficacy. Su Z; You L; He Y; Chen J; Zhang G; Liu Z Sci Rep; 2024 Jan; 14(1):2189. PubMed ID: 38273010 [TBL] [Abstract][Full Text] [Related]
3. ARNTL2 facilitates bladder cancer progression through potentiating ENO1-mediated glycolysis in a SLC31A1-independent and -dependent manner. Wang J; Ren J; Tu X; Yuan H; Ye Z; Wang X; Cui J; Wang J; Tang Y; Han P; Bai Y Life Sci; 2024 Oct; 355():122974. PubMed ID: 39147318 [TBL] [Abstract][Full Text] [Related]
4. FGL2 as a predictive biomarker for prognosis and immunotherapy in bladder cancer. Huang Z; Wang Z; Xu C; Yan Y; Cao X; Zhang F; Shen B Int J Med Sci; 2024; 21(8):1447-1460. PubMed ID: 38903931 [No Abstract] [Full Text] [Related]
5. Comprehensive Analysis Identified ETV7 as a Potential Prognostic Biomarker in Bladder Cancer. Li H; Zhang Y; Zheng S Biomed Res Int; 2021; 2021():8530186. PubMed ID: 34926692 [TBL] [Abstract][Full Text] [Related]
6. Melatonin inhibits bladder tumorigenesis by suppressing PPARĪ³/ENO1-mediated glycolysis. Shen D; Deng Z; Liu W; Zhou F; Fang Y; Shan D; Wang G; Qian K; Yu M; Zhang Y; Ju L; Xiao Y; Wang X Cell Death Dis; 2023 Apr; 14(4):246. PubMed ID: 37024456 [TBL] [Abstract][Full Text] [Related]
7. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer. Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation. Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P Front Immunol; 2023; 14():955949. PubMed ID: 37006317 [TBL] [Abstract][Full Text] [Related]
9. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer. Wang Z; Tu L; Chen M; Tong S BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144 [TBL] [Abstract][Full Text] [Related]
10. Multiple omics integrative analysis identifies GARS1 as a novel prognostic and immunological biomarker: from pan-cancer to bladder cancer. Liu W; Wei C; He Q; Chen Z; Zhuang W; Guo Y; Xue X Sci Rep; 2024 Aug; 14(1):19025. PubMed ID: 39152248 [TBL] [Abstract][Full Text] [Related]
11. Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer. Zhang Z; Yu Y; Zhang P; Ma G; Zhang M; Liang Y; Jiao W; Niu H BMC Cancer; 2021 Apr; 21(1):458. PubMed ID: 33894748 [TBL] [Abstract][Full Text] [Related]
12. Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors. Cancemi P; Buttacavoli M; Roz E; Feo S Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31416219 [TBL] [Abstract][Full Text] [Related]
13. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma. White-Al Habeeb NM; Di Meo A; Scorilas A; Rotondo F; Masui O; Seivwright A; Gabril M; Girgis AH; Jewett MA; Yousef GM Clin Exp Metastasis; 2015 Aug; 32(6):531-41. PubMed ID: 26037892 [TBL] [Abstract][Full Text] [Related]
14. Enolase1 overexpression regulates the growth of gastric cancer cells and predicts poor survival. Qiao H; Wang Y; Zhu B; Jiang L; Yuan W; Zhou Y; Guan Q J Cell Biochem; 2019 Nov; 120(11):18714-18723. PubMed ID: 31218757 [TBL] [Abstract][Full Text] [Related]
15. Impact of Tissue Enolase 1 Protein Overexpression in Esophageal Cancer Progression. Hoang AT; Vizio B; Chiusa L; Cimino A; Solerio D; Do NH; Pileci S; Camandona M; Bellone G Int J Med Sci; 2021; 18(6):1406-1414. PubMed ID: 33628097 [TBL] [Abstract][Full Text] [Related]
16. KLK6 Functions as an Oncogene and Unfavorable Prognostic Factor in Bladder Urothelial Carcinoma. Zhao K; Gao M; Lin M Dis Markers; 2022; 2022():3373851. PubMed ID: 36193495 [TBL] [Abstract][Full Text] [Related]
17. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer. Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465 [TBL] [Abstract][Full Text] [Related]
18. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer. Chen F; Wang Q; Zhou Y BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397 [TBL] [Abstract][Full Text] [Related]
19. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer. Lu H; Wu J; Liang L; Wang X; Cai H Front Immunol; 2022; 13():803355. PubMed ID: 35154117 [TBL] [Abstract][Full Text] [Related]
20. Integrated transcriptome analysis of CSE1L regarding poor prognosis and immune infiltration in bladder urothelial carcinoma and experimental verification. Liu R; Ma J; Zhang Y; Zhou Z Front Immunol; 2024; 15():1449251. PubMed ID: 39430746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]